BetterScholar BetterScholar

G. Vega

Proceedings of the National Academy of Sciences of the United States of America, Circulation, Journal of the American Medical Association, Archives of Internal Medicine, American Journal of Human Genetics, Journal of Lipid Research, Obesity, Journal of the American Society of Nephrology, Hepatology, Journal of Clinical Endocrinology and Metabolism Show more
12
Role
Title
Level Year L/R
🐜 Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.
10 auth. I. Neeland, A. Turer, C. Ayers, Tiffany Powell-wiley, G. Vega, R. Farzaneh-Far, ... S. Grundy, A. Khera, Darren K Mcguire, J. D. de Lemos 		9 2012
9
🐜
🐜 Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
11 auth. S. Grundy, G. Vega, M. McGovern, B. Tulloch, D. Kendall, D. Fitz-Patrick, ... O. Ganda, R. Rosenson, J. Buse, D. Robertson, J. Sheehan 		9 2002
9
🐜
🐜 A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.
7 auth. I. Kotowski, A. Pertsemlidis, A. Luke, R. Cooper, G. Vega, Jonathan C. Cohen, ... H. Hobbs 		9 2006
9
🐜
🐜 Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
7 auth. R. Bucala, Z. Makita, G. Vega, S. Grundy, T. Koschinsky, A. Cerami, ... H. Vlassara 		8 1994
8
🐜
🐜 Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
10 auth. T. Innerarity, R. Mahley, K. Weisgraber, T. Bersot, R. Krauss, G. Vega, ... S. Grundy, Walter Friedl, J. Davignon, Brian J. McCarthy 		8 1990
8
🐜
🐜 Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study
11 auth. Sandeep R. Das, M. Drazner, D. Dries, G. Vega, H. G. Stanek, Shuaib M. Abdullah, ... R. Canham, Anne K. Chung, D. Leonard, F. Wians, J. D. de Lemos 		8 2005
8
🐜
🐜 Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults
11 auth. I. Neeland, C. Ayers, Anand Rohatgi, A. Turer, J. Berry, Sandeep R. Das, ... G. Vega, A. Khera, D. McGuire, S. Grundy, J. D. de Lemos 		8 2012
8
🐜
🐜 Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.
7 auth. Jonathan C. Cohen, A. Pertsemlidis, Saleemah Fahmi, Sophie Esmail, G. Vega, S. Grundy, ... H. Hobbs 		8 2006
8
🐜
🐬 Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.
Uzma F Mehdi, B. Adams-Huet, P. Raskin, G. Vega, R. Toto 		8 2009
8
🐬
🐬 Ethnic differences in hepatic steatosis: An insulin resistance paradox?
Richard Guerrero, G. Vega, S. Grundy, J. Browning 		8 2009
8
🐬
🐢 Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors.
10 auth. S. Grundy, A. Garber, R. Goldberg, S. Havas, R. Holman, C. Lamendola, ... W. Howard, P. Savage, J. Sowers, G. Vega 		8 2002
8
🐢
🦁 Influence of body fat content and distribution on variation in metabolic risk.
G. Vega, B. Adams-Huet, R. Peshock, D. Willett, B. Shah, S. Grundy 		8 2006
8
🦁